WHO ICTRP trial

Phase I Study to Evaluate Safety of LSCD101(Cultured Autologous Limbal…

KCT0004741 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0004741
Public title Phase I Study to Evaluate Safety of LSCD101(Cultured Autologous Limbal Epithelial Cell Sheet) Transplantation for Limbal Stem Cell Deficiency
Scientific title Phase I Study to Evaluate Safety of LSCD101(Cultured Autologous Limbal Epithelial Cell Sheet) Transplantation for Limbal Stem Cell Deficiency
Primary sponsor CliPS
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Phase1
Countries Korea, Republic of
Conditions Diseases of the eye and adnexa
Interventions Biological/Vaccine, Stem Cell : 1) All the conjunctivalized parts containing the vessels on the cornea are peeled off with a blade. 2) The cultured autologous limbal epithelial cell sheet attached to the amnion is carefully transplanted and…
Registration date Feb 17, 2020
Target size 6
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations